Long-term Outcomes of SMILE PRO for High Astigmatism
Outcomes of SMILE PRO Surgery for the Correction of Myopia With High Astigmatism
1 other identifier
interventional
113
1 country
1
Brief Summary
This prospective interventional study aims to evaluate the long-term refractive and visual quality outcomes of SMILE PRO surgery in patients with myopia and high astigmatism. Eligible participants undergo small incision lenticule extraction using the VisuMax 800 femtosecond laser. Postoperative assessments include uncorrected and corrected distance visual acuity, manifest refraction, astigmatic vector analysis, contrast sensitivity, and higher-order aberrations. Participants are followed for up to 12 months to assess refractive accuracy, stability, safety, and visual quality after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedFirst Submitted
Initial submission to the registry
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
March 3, 2026
February 1, 2026
1.8 years
February 10, 2026
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Residual Refractive Astigmatism
Residual refractive astigmatism was measured using manifest refraction and analyzed with astigmatic vector analysis based on the Alpins method.
12 months postoperatively
Refractive Accuracy (Spherical Equivalent Error)
Refractive accuracy was assessed using manifest refraction spherical equivalent (SEQ) after SMILE PRO surgery.
12 months postoperatively
Secondary Outcomes (13)
Refractive Stability Over Time (Spherical Equivalent)
1 week, 1 month, 3 months, 6 months, and 12 months postoperatively
Refractive Cylinder Over Time
1 week, 1 month, 3 months, 6 months, and 12 months postoperatively
Uncorrected Distance Visual Acuity (UDVA)
1 week, 1 month, 3 months, 6 months, and 12 months postoperatively
Corrected Distance Visual Acuity (CDVA)
1 month, 3 months, 6 months, and 12 months postoperatively
Surgically Induced Astigmatism (SIA)
3 months and 12 months postoperatively
- +8 more secondary outcomes
Study Arms (1)
SMILE PRO surgery
EXPERIMENTALParticipants with myopia and high astigmatism undergoing small incision lenticule extraction using the SMILE PRO surgery.
Interventions
Small incision lenticule extraction surgery performed using the VisuMax 800 femtosecond laser (SMILE PRO) for the correction of myopia with high astigmatism. The procedure is performed by a single experienced ophthalmic surgeon following a standardized surgical protocol.
Eligibility Criteria
You may qualify if:
- Patients aged 18 to 40 years at the time of surgery
- Diagnosis of myopia with high astigmatism eligible for SMILE PRO surgery
- Stable refractive error prior to surgery
- Adequate corneal thickness and topographic parameters suitable for SMILE PRO
- Ability to understand the study procedures and provide written informed consent
- Willingness and ability to attend scheduled postoperative follow-up visits
You may not qualify if:
- Presence of corneal ectatic disorders or suspicious corneal topography
- History of previous ocular surgery or ocular trauma
- Active ocular disease other than refractive error
- Systemic diseases known to affect wound healing
- Pregnancy or breastfeeding at the time of surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Son Eye Hospital
Hanoi, Hanoi, 100000, Vietnam
Related Publications (4)
Reinstein DZ, Archer TJ, Potter JG, Gupta R, Wiltfang R. Refractive and Visual Outcomes of SMILE for Compound Myopic Astigmatism With the VISUMAX 800. J Refract Surg. 2023 May;39(5):294-301. doi: 10.3928/1081597X-20230301-02. Epub 2023 May 1.
PMID: 37162399BACKGROUNDPedersen IB, Ivarsen A, Hjortdal J. Changes in Astigmatism, Densitometry, and Aberrations After SMILE for Low to High Myopic Astigmatism: A 12-Month Prospective Study. J Refract Surg. 2017 Jan 1;33(1):11-17. doi: 10.3928/1081597X-20161006-04.
PMID: 28068441BACKGROUNDChan TCY, Wang Y, Ng ALK, Zhang J, Yu MCY, Jhanji V, Cheng GPM. Vector analysis of high (>/=3 diopters) astigmatism correction using small-incision lenticule extraction and laser in situ keratomileusis. J Cataract Refract Surg. 2018 Jul;44(7):802-810. doi: 10.1016/j.jcrs.2018.04.038. Epub 2018 Jun 13.
PMID: 29909252BACKGROUNDZhou J, Gu W, Gao Y, He G, Zhang F. Vector analysis of high astigmatism (>/= 2.0 diopters) correction after small-incision lenticule extraction with stringent head positioning and femtosecond laser-assisted laser in situ keratomileusis with compensation of cyclotorsion. BMC Ophthalmol. 2022 Apr 5;22(1):157. doi: 10.1186/s12886-022-02384-0.
PMID: 35382779BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Lan Tran, MD
Hanoi Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2026
First Posted
March 3, 2026
Study Start
December 10, 2024
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available beginning 12 months after publication of the primary results and will remain available for 5 years.
- Access Criteria
- Data will be shared with qualified researchers who submit a methodologically sound proposal. Requests will be reviewed by the study investigators, and data access will be granted after approval of the proposal and signing of a data use agreement.
De-identified individual participant data underlying the results reported in this study will be made available. Shared data will include demographic characteristics, preoperative and postoperative refractive outcomes, visual acuity measurements, astigmatic vector parameters, contrast sensitivity results, and wavefront-derived higher-order aberrations. No personally identifiable information will be shared.